Abstract:RNA interference (RNAi) is being evaluated as an alternative therapeutic strategy for hepatitis C virus (HCV) infection The use of viral vectors encoding short hairpin RNAs (shRNAs) has been the most common strategy employed to provide sustained expression of RNAi effectors However, overexpression and incomplete processing of shRNAs has led to saturation of the endogenous miRNA pathway, resulting in toxicity The use of endogenous microRNAs (miRNAs) as scaffolds for short interfering (siRNAs) may avoid these problems, and miRNA clusters can be engineered to express multiple RNAi effectors, a feature that may prevent RNAi-resistant HCV mutant generation We exploited the endogenous miRNA-17-92 duster to generate a polycistronic primary miRNA that is processed into five mature miRNAs that target different regions of the HCV genome All five anti-HCV miRNAs were active, achieving up to 97% inhibition of Renilla luciferase (RLuc) HCV reporter plasmids Self-complementary recombinant adeno-associated virus (scAAV) vectors were chosen for therapeutic delivery of the miRNA duster Expression of the miRNAs from scAAV inhibited the replication of cell culture propagated HCV (HCVcc) by 98%, and resulted in up to 93% gene silencing of RLuc-HCV reporter plasmids in mouse liver No hepatocellular toxicity was observed at scAAV doses as high as 5 x 10(11) vector genomes per mouse, a dose that is approximately five-fold higher than doses of scAAV-shRNA vectors that others have shown previously to be toxic in mouse liver Conclusion. We have demonstrated that exogenous anti-HCV miRNAs induce gene silencing, and when expressed from scAAV vectors inhibit the replication of HCVcc without inducing toxicity The combination of an AAV vector delivery system and exploitation of the endogenous RNAI pathway is a potentially viable alternative to current HCV treatment regimens (HEPATOLOGY 2010,52 1877-1887)

A Novel Strategy to Inhibit the Reproduction and Translation of Hepatitis C Virus

RNA Interference Effectively Inhibits Mrna Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells

Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot

Inhibition of Hepatitis C Virus Replication Using Adeno-Associated Virus Vector Delivery of an Exogenous Anti-Hepatitis C Virus Microrna Cluster

Inhibition of Hepatitis C Virus Replication and Expression by Small Interfering Rna Targeting Host Cellular Genes

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Simple and Rational Design of a Polymer Nano-Platform for High Performance of HCV Related Mir-122 Reduction in the Liver

Inhibition of Hepatitis C Virus Replication by Single and Dual Small Interfering RNA Using an HCV-infected Cell Model

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

Inhibition of HCV translation by disrupting the structure and interactions of the viral CRE and 3′ X-tail

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA

Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme

[Research Advances on Treatment of Hepatitis C Infection Based on RNA Interference and Microrna Modulation].

[Inhibition of Hepatitis C Virus Gene Expression by Antisense Nucleotide in Vitro].

[Inhibition of hepatitis C virus replication by small interfering RNA in cells infected by HCV].

Combining RNA Interference and RIG-I Activation to Inhibit Hepatitis E Virus Replication

Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C

Mechanistic Insights into the Protection Effect of Argonaute–RNA Complex on the HCV Genome

Generation of hepatitis C virus-resistant liver cells by genome editing-mediated stable expression of RNA aptamer

A miRNA-responsive cell-free translation system facilitates isolation of hepatitis C virus miRNP complexes